Type(s) of breast cancer-Invasive ductal / lobular carcinoma Posts on Medivizor
Navigation Menu

Type(s) of breast cancer-Invasive ductal / lobular carcinoma Posts on Medivizor

Chemotherapy in patients with hormone receptor positive, node positive invasive breast cancer

Posted by on Dec 30, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out how well chemotherapy for invasive breast cancer works, especially in those over 70 years old. The study found that most patients benefit from chemotherapy, however, those aged over 70 benefited less of this treatment than those aged under 70. Some background Most types of breast cancer have guidelines with...

Read More

A comparison of how FEC120 treatment vs EC-docetaxel treatment affect survival in patients with node-positive primary breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study compared the side effects and outcome of two drug regimens in women with high-risk node-positive breast cancer (BC). Both treatment regimens were found to have similar survival outcomes. Some background Standard treatment in node positive BC (cancer that has spread to the lymph nodes) consists of two categories of...

Read More

Comparing axillary lymph node ultrasound and fine needle aspiration in breast cancer

Posted by on Mar 4, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether patients with a suspicious axillary lymph node (ALN) but negative fine-needle aspiration result (FNA) can be considered as having node-negative disease (AUN). The study concluded that patients with suspicious ALN on ultrasound but negative FNA results can be treated as having node-negative disease. Some...

Read More

Invasive breast cancer: a review

Posted by on Aug 9, 2016 in Breast cancer | 0 comments

In a nutshell This review outlined the recommended treatment options for invasive breast cancer.  Some background Breast cancer is the most commonly diagnosed cancer in the world and it is the leading cause of cancer-related death in women. Breast cancer often begins in the milk ducts and lobules. In invasive breast cancer, the cancer moves...

Read More

Can pertuzumab improve long-term response rates in HER2-positive breast cancer?

Posted by on Mar 14, 2016 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess whether adding pertuzumab (Perjeta) to chemotherapy could improve response in women with metastatic (has spread) breast cancer. This study showed that adding pertuzumab to chemotherapy resulted in higher response rates among women with breast cancer that relied on the human epidermal growth factor 2 (HER2) to...

Read More